Replimune Group, Inc.

NasdaqGS:REPL Stock Report

Market Cap: US$719.4m

Replimune Group Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:REPL Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
16 Aug 24SellUS$90,989Emily HillIndividual8,938US$10.18
16 May 24SellUS$130,655Sushil PatelIndividual20,194US$6.47
16 May 24SellUS$245,394Philip Astley-SparkeIndividual37,928US$6.47
16 May 24SellUS$113,969Colin LoveIndividual17,615US$6.47
16 May 24SellUS$14,868Andrew SchwendenmanIndividual2,298US$6.47
16 May 24SellUS$41,194Konstantinos XynosIndividual6,367US$6.47
16 May 24SellUS$74,172Robert CoffinIndividual11,464US$6.47
16 May 24SellUS$14,350Christopher SarchiIndividual2,218US$6.47
16 Nov 23SellUS$57,385Christopher SarchiIndividual5,255US$10.92
16 Nov 23SellUS$79,858Konstantinos XynosIndividual7,313US$10.92

Insider Trading Volume

Insider Buying: REPL insiders have only sold shares in the past 3 months.


Ownership Breakdown

What is the ownership structure of REPL?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders4,083,6635.41%
VC/PE Firms4,866,4496.45%
Hedge Funds15,607,43220.7%
Institutions50,887,43167.4%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 15.8%.


Top Shareholders

Top 25 shareholders own 92.29% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14.7%
Baker Bros. Advisors LP
10,045,336US$105.8m5.24%1.05%
13.5%
T. Rowe Price Group, Inc.
9,236,057US$97.3m41%0.01%
8.14%
Redmile Group, LLC
5,562,096US$58.6m49.1%2.78%
7.12%
Forbion Capital Partners B.V.
4,866,449US$51.2m0%8.75%
6.9%
BlackRock, Inc.
4,713,791US$49.6m2.19%no data
4.56%
Millennium Management LLC
3,118,035US$32.8m575%0.03%
4.24%
The Vanguard Group, Inc.
2,895,114US$30.5m4.5%no data
3.6%
Omega Fund Management, LLC
2,461,319US$25.9m-18%19.65%
3.07%
Atlas Venture L.P.
2,098,300US$22.1m0%2.06%
2.57%
Robert Coffin
1,755,779US$18.5m1.48%no data
2.32%
Morgan Stanley, Investment Banking and Brokerage Investments
1,586,032US$16.7m-37.6%no data
2.25%
Tavistock Life Sciences
1,536,341US$16.2m0%0.78%
1.98%
Camber Capital Management LP
1,350,000US$14.2m-50.9%0.52%
1.87%
Philip Astley-Sparke
1,274,421US$13.4m-3.78%no data
1.77%
Geode Capital Management, LLC
1,210,993US$12.8m1.61%no data
1.69%
State Street Global Advisors, Inc.
1,157,861US$12.2m-82.2%no data
1.66%
RTW Investments, LP
1,133,787US$11.9m0%0.18%
1.48%
Braidwell LP
1,013,377US$10.7m0%0.49%
1.46%
Jefferies Group LLC, Asset Management Arm
1,000,000US$10.5m0%0.76%
1.44%
Schonfeld Strategic Advisors LLC
981,235US$10.3m520%0.08%
1.36%
D. E. Shaw & Co., L.P.
931,780US$9.8m-6.62%0.01%
1.24%
EcoR1 Capital, LLC
850,341US$9.0m0%0.27%
1.18%
Tang Capital Management, LLC
805,440US$8.5m0%0.76%
1.09%
FMR LLC
747,188US$7.9m161%no data
1.06%
Colin Love
724,399US$7.6m1.23%no data